Sorabh Datta Shivangi Singh Raghav Govindarajan
10.3233/JND-190464
J Neuromuscul Dis
2020;7(3):269-277.
ach receptors myasthenia gravis activities of daily living complement inactivating agents corticosteroids neuromuscular junction
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32444555/
Antibodies, Monoclonal, Humanized / pharmacology Complement Inactivating Agents / pharmacology Myasthenia Gravis / drug therapy Outcome Assessment, Health Care
Antibodies, Monoclonal, Humanized / pharmacology Complement Inactivating Agents / pharmacology Myasthenia Gravis / drug therapy Outcome Assessment, Health Care Activities of Daily Living Adult Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / adverse effects Complement Inactivating Agents / administration & dosage Complement Inactivating Agents / adverse effects Female Humans Middle Aged Myasthenia Gravis / immunology Receptors, Cholinergic / immunology Retrospective Studies Antibodies, Monoclonal, Humanized Complement Inactivating Agents Receptors, Cholinergic eculizumab
PMC7369065
32444555
Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series
2020